The Clinical and Economic Potential of Cyclosporin Drug Interactions Jill E. MartinA. Jamal DaoudM. Roy First Review Article 11 October 2012 Pages: 317 - 337
Methodological Hurdles in Conducting Pharmacoeconomic Analyses J. Douglas RizzoNeil R. Powe Review Article 11 October 2012 Pages: 339 - 355
Recent Advances in the Methods of Cost-Benefit Analysis in Healthcare Emma McIntoshCam DonaldsonMandy Ryan Review Article 11 October 2012 Pages: 357 - 367
Utility Scores for Chronic Conditions in a Community-Dwelling Population Nicole MittmannKostas TrakasBarbara A. Liu Original Research Article 11 October 2012 Pages: 369 - 376
Treatment of Locally Advanced Pancreatic Carcinoma in Sweden Gunnel Ragnarson-TennvallNils Wilking Original Research Article 11 October 2012 Pages: 377 - 384
Applying Epidemiology-Based Outcomes Research to Clinical Decision-Making Edward C. Y. WangThaddeus H. GraselaCynthia A. Walawander Original Research Article 11 October 2012 Pages: 385 - 393
Cost Analysis of the Treatment of Severe Spinal Spasticity With a Continuous Intrathecal Baclofen Infusion System Theo PostmaDettie OenemaBerry J. Middel Original Research Article 11 October 2012 Pages: 395 - 404
Vinorelbine in Advanced Non–Small Cell Lung Cancer Allan J. CoukellStuart NobleDiana Faulds Adis Pharmacoeconomic Drug Evaluation 11 October 2012 Pages: 405 - 417